| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |